We examined the change in liver by HE staining and found that fat deposition in liver increased in all EPA administration groups
See our authentic success stories
Always trust the quality I love that the COA is always consistent every time I buy
13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [5-, 17-, and 59-fold the maximum recommended human dose (MRHD) of 1 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (2-, 5-, and 17-fold MRHD) were administered to the females
Individual responses vary considerably, and not everyone achieves the average weight loss seen in clinical trials
Does the price increase as the dose increases